Generating signals of drug‐adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials
暂无分享,去创建一个
Giovanni Corrao | Antonella Zambon | G. Corrao | E. Botteri | V. Bagnardi | Olivia Leoni | Vincenzo Bagnardi | A. Zambon | Edoardo Botteri | Chiara Falcone | A. Carobbio | Alessandra Carobbio | O. Leoni | C. Falcone
[1] J. Hallas. Evidence of Depression Provoked by Cardiovascular Medication: A Prescription Sequence Symmetry Analysis , 1996, Epidemiology.
[2] H. Petri,et al. Prescription sequence analysis: a new and fast method for assessing certain adverse reactions of prescription drugs in large populations. , 1988, Statistics in medicine.
[3] G Lindberg,et al. Cholesterol‐lowering drugs and antidepressants—A study of prescription symmetry , 1998, Pharmacoepidemiology and drug safety.
[4] B. Stricker,et al. The risk of acute pancreatitis associated with acid-suppressing drugs. , 2000, British journal of clinical pharmacology.
[5] S. Shakir,et al. Profiles of Hepatic and Dysrhythmic Cardiovascular Events Following Use of Fluoroquinolone Antibacterials , 2001, Drug safety.
[6] Drug exposure risk windows and unexposed comparator groups for cohort studies in pharmacoepidemiology , 1998, Pharmacoepidemiology and drug safety.
[7] Jonathan A C Sterne,et al. Sifting the evidence—what's wrong with significance tests? , 2001, BMJ : British Medical Journal.
[8] A. Walker. Confounding by indication. , 1996, Epidemiology.
[9] M. Schulzer,et al. 'Unqualified success' and 'unmitigated failure': number-needed-to-treat-related concepts for assessing treatment efficacy in the presence of treatment-induced adverse events. , 1996, International journal of epidemiology.
[10] H. Jick,et al. Principles of epidemiological research on adverse and beneficial drug effects , 1998, The Lancet.
[11] R. Frothingham,et al. Rates of Torsades de Pointes Associated with Ciprofloxacin, Ofloxacin, Levofloxacin, Gatifloxacin, and Moxifloxacin , 2001, Pharmacotherapy.
[12] H. Petri,et al. Rapid method for estimating the risk of acutely controversial side effects of prescription drugs. , 1990, Journal of clinical epidemiology.
[13] J. Hallas,et al. Drug‐induced symptoms of functional dyspepsia and nausea. A symmetry analysis of one million prescriptions , 2000, Alimentary pharmacology & therapeutics.
[14] N. Breslow,et al. Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.
[15] G. Breithardt,et al. Divergent Proarrhythmic Potential of Macrolide Antibiotics Despite Similar QT Prolongation: Fast Phase 3 Repolarization Prevents Early Afterdepolarizations and Torsade de Pointes , 2002, Journal of Pharmacology and Experimental Therapeutics.
[16] J Urquhart,et al. Channeling bias in the interpretation of drug effects. , 1991, Statistics in medicine.
[17] Maurizio Recanatini,et al. Safety of Non-Antiarrhythmic Drugs that Prolong the QT Interval or Induce Torsade de Pointes , 2002, Drug safety.
[18] R. Owens,et al. Torsades de Pointes Associated with Fluoroquinolones , 2002, Pharmacotherapy.
[19] D J Triggle,et al. Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG. , 2001, Molecular pharmacology.
[20] N. Breslow,et al. Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .
[21] S. Viskin,et al. Long QT syndrome caused by noncardiac drugs. , 2003, Progress in cardiovascular diseases.
[22] H. Kotaki,et al. Comparative Pharmacodynamic Analysis of Q-T Interval Prolongation Induced by the Macrolides Clarithromycin, Roxithromycin, and Azithromycin in Rats , 2000, Antimicrobial Agents and Chemotherapy.
[23] J. Evans,et al. Misclassification and selection bias in case–control studies using an automated database , 1997, Pharmacoepidemiology and drug safety.